DALLAS, Oct. 12, 2017 -- Capital Southwest Corporation (“Capital Southwest” or the “Company”) (Nasdaq:CSWC) announced today that it will release its second quarter 2018 results on Monday, November 6, 2017 after the market closes. In conjunction with the release, Capital Southwest has scheduled a conference call which will be broadcast live via phone and over the Internet on Tuesday, November 7, 2017 at 11:00 a.m. Eastern time. Investors may participate either by phone or audio webcast.
By Phone:
Dial (866)-502-8274 and provide the operator with Conference ID 96686873 at least 10 minutes before the call. A replay of the conference call will be available shortly afterwards until November 14, 2017, by dialing (855)-859-2056 and entering Conference ID 96686873.
By Webcast:
Connect to the webcast using the Investor Relations section of Capital Southwest's website at www.capitalsouthwest.com, or by using https://edge.media-server.com/m6/p/h2ri2jhw. Please log in at least 10 minutes in advance to register and download any necessary software. A replay of the conference call will be available on Capital Southwest's website shortly after the call.
About Capital Southwest
Capital Southwest Corporation (Nasdaq:CSWC) is a Dallas, Texas-based, Internally Managed Business Development Company which has net assets of approximately $287 million as of June 30, 2017. Capital Southwest is a middle-market lending firm focused on supporting the acquisition and growth of middle market businesses. Capital Southwest makes investments ranging from $5 to $20 million in securities across the capital structure, including first lien, unitranche, second lien, subordinated debt and non-control equity co-investments. As a public company with a permanent capital base, Capital Southwest has the flexibility to be creative in its financing solutions and to invest to support the growth of its portfolio companies over long periods of time.
Forward-Looking Statements
This press release contains historical information and forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 with respect to the business and investments of Capital Southwest. Forward-looking statements are statements that are not historical statements and can often be identified by words such as "will," "believe," "expect" and similar expressions and variations or negatives of these words. These statements are based on management's current expectations, assumptions and beliefs. They are not guarantees of future results and are subject to numerous risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statement. These risks include risks related to changes in the markets in which Capital Southwest invests, changes in the financial and lending markets, regulatory changes, tax treatment and general economic and business conditions.
Readers should not place undue reliance on any forward-looking statements and are encouraged to review Capital Southwest's Annual Report on Form 10-K for the year ended March 31, 2017 and subsequent filings with the Securities and Exchange Commission for a more complete discussion of the risks and other factors that could affect any forward-looking statements. Except as required by the federal securities laws, Capital Southwest does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.
Investor Relations Contact:
Michael S. Sarner, Chief Financial Officer
214-884-3829


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 



